胰岛淀粉样多肽在豚鼠胰腺分布的免疫组织化学研究

本文用免疫组织化学ＡＢＣ法,研究了胰岛淀粉样多肽（Ｉｓｌｅｔａｍｙｌｏｉｄｐｏｌｙｐｅｐｔｉｄｅ,ＩＡＰＰ或称Ａｍｙｌｉｎ）在豚鼠胰脏的分布,并用邻片免疫组织化学双标记法,观察了ＩＡＰＰ与胰岛素（Ｉｎｓｕｌｉｎ,ＩＮＳ）、生长抑素（ＳｏｍａｔｏｓｔａｔｉｎＳＳ）的共存关系。结果显示,豚鼠胰岛内绝大多数细胞都呈ＩＡＰＰ阳性免疫反应,在胰外分泌部的腺泡和导管内也散在分布有ＩＡＰＰ免疫反应阳性细胞。多数ＩＡＰＰ免疫反应阳性的细胞都显示ＩＮＳ免疫反应阳性,胰岛内少数ＩＡＰＰ阳性细胞也呈ＳＳ免疫反应阳性。说明ＩＡＰＰ主要分布在豚鼠的胰岛内．但也少量存在于外分泌部。ＩＡＰＰ主要和ＩＮＳ共存于Ｂ细胞内。但也和ＳＳ共存于Ｄ细胞内,提示ＩＡＰＰ可能通过自分泌途径调节ＩＮＳ和ＳＳ的分泌。     

电损毁海马CA_3区及连合前穹窿对大鼠血浆胰岛素水平及胰岛细胞的影响

电损毁大鼠海马CA_3区(HCA_3-EL)或连合前穹窿纤维(ACHF-EL)后,其血浆胰岛素基础水平明显升高。HCA_3-EL两周后,大鼠空腹血糖浓度增高,且糖耐量降低。但胰岛B细胞对葡萄糖刺激之分泌反应却显著增强。HCA_3-EL或ACHF-EL大鼠经静脉糖耐量试验(IVGTT)后,其胰岛A细胞内胰高血糖素样及B细胞内胰岛素样免疫阳性物质的相对含量均明显低于对照组。HCA_3-EL组大鼠胰岛中生长抑素样免疫阳性物质的相对含量及阳性细胞数目均较对照组减少,而胰岛中胰多肽样免疫阳性物质却无明显变化。上述结果表明,海马CA_3区(HCA_3)及连台前穹窿(ACHF)对胰岛素的分泌有紧张性抑制作用。     

瞬时外向钾电流的降低介导了慢性压迫背根神经节细胞兴奋性的升高

慢性压迫大鼠背根神经节（chronic compression of the dorsal root,ganglion,CCD）后,背根神经节细胞兴奋性升高,但引起神经元兴奋性改变的离子通道机制还需进一步探索。本实验采用胞内记录以及全细胞膜片钳记录方法,研究急性分离的大鼠背根神经节细胞兴奋性改变与瞬时外向钾电流（A-type potassium current,ⅠA）的关系。结果表明,CCD术后背根神经节细胞兴奋性升高,在急性分离的体外细胞中仍继续存在,表现为对辣椒素敏感的背根神经节细胞产生动作电位的最小电流刺激强度,即阈电流（current threshold）及阈电位（voltage threshold）降低;给予正常对照组神经元（未压迫损伤）瞬时外向钾通道阻断剂4-氨基吡啶,出现了类似CCD术后兴奋性升高的改变。进一步用两步电压钳方法分离ⅠA,研究CCD术后神经元ⅠA的变化,结果表明,CCD组神经元的ⅠA比对照组神经元ⅠA降低,并且与其阈电位的改变一致。以上结果提示,背根神经节压迫受损后,神经节细胞ⅠA降低可能参与介导了神经节细胞兴奋性的升高。     

胰岛结构与功能调节新貌

近十余年来,由于生物科学技术的迅猛发展,胰岛内分泌学已呈现出一副新的面貌。从胰岛中已识别出7种不同的分泌细胞,已知分泌至少4种多肽激素,即胰岛素、高血糖素、生长抑素和胰多肽。对前二者正进行更较深入的研究;对胰岛生长抑素在营养物质稳态中的作用,正在大力研究;而胰多肽的作用还是一个谜。但胰岛内分泌的研究前景是未可限量的。     

肝细胞生长因子在正常大鼠腰段脊髓和背根神经节的表达

目的:观察肝细胞生长因子(hepatocyte growth factor,HGF)在大鼠脊髓和背根神经节(dorsal root ganglion,DRG)的表达。方法:取健康成年6只SD大鼠运用免疫组织化学染色技术检测HGF在腰段脊髓、背根神经节内的表达和分布。结果:在L4-6段脊髓,HGF免疫阳性产物可见于各板层神经元,尤以脊髓前角运动神经元明显;在DRG中,HGF免疫阳性物质可见于以大、中型为主的神经元的胞浆及突起中。结论:脊髓和背根神经节内的HGF通过与受体c-Met结合可能在神经再生及突触可塑性方面起一定作用。     

P2X_3受体在感觉神经节的表达

用免疫组织化学与原位杂交研究 P2 X3受体在背根神经节、三叉神经节和结状神经节的分布。结果显示 :1.原位杂交 :在三种感觉神经节中 ,95 %左右的神经节细胞为 P2 X3m RNA阳性 ,中、小型神经节细胞的杂交信号一般要比大型的神经节细胞强一些。 2 .免疫组织化学 :免疫组织化学结果与原位杂交结果基本一致。此外 ,在各神经节内 ,均显示出许多P2 X3免疫阳性神经纤维 ,在足掌表皮也显示许多 P2 X3免疫反应阳性纤维。结果提示 :P2 X3不仅参与机体的痛觉的形成 ,还可能参与其它感觉 ,如本体感觉等的形成     

大鼠背根神经节细胞膜蛋白的提取及双向凝胶电泳分离

为了开展大鼠背根神经节(DRG)细胞质膜蛋白质组学研究,取成年大鼠的背根神经节,用胰蛋白酶和胶原酶等消化处理后经密度梯度离心分离DRG细胞质膜;用裂解液裂解提取膜蛋白并通过双向凝胶电泳将膜蛋白分离.扫描凝胶图谱后进行图像分析,结果表明DRG细胞膜蛋白得到了有效的提取和分离.双向凝胶电泳图谱的建立为进一步进行DRG细胞质膜蛋白质组学的研究提供了重要的基础.     

大鼠脊神经节感觉神经特异蛋白35kD(SSP-35)的纯化及鉴定(英文)

 以大鼠脊髓背根神经节及背根纤维组织为材料 ,通过离子交换层析 ,FPLC凝胶过滤等技术分离纯化了脊感觉神经特异蛋白 35kD(SSP 35) .经SDS PAGE分析 ,该蛋白特异地存在于脊感觉神经而不存在于脊运动神经 .非还原电泳结果表明 ,该蛋白分子内含有巯基 ,有二聚体存在 .根据HPLC测定 ,蛋白纯度达 90 %以上 .将此蛋白给予培养的PC 1 2细胞 ,观察到它具有神经营养作用 .     

降钙素基因相关肽(CGRP)mRNA在大鼠淋巴细胞中的表达

最近,我们研究发现大鼠胸腺和淋巴结淋巴细胞中存在降钙素基因相关肽（ＣＧＲＰ）样免疫反应活性。应用人工合成的可特异扩增降钙素／降钙素基因相关肽基因部分片断的寡核苷酸引物,通过逆转录－多聚酶链反应（ＲＴ－ＰＣＲ）,检测在大鼠脊髓背根神经节、胸腺细胞及肠系膜淋巴结淋巴细胞中是否存在ＣＧＲＰ ｍＲＮＡ,进一步研究大鼠淋巴细胞能否合成ＣＧＲＰ。结果显示,通过ＲＴ－ＰＣＲ从脊髓背根神经节（阳性对照）、胸腺和淋     

P2X3受体在感觉神经节的表达

用免疫组织化学与原位杂交研究P2X3受体在背根神经节,三叉神经节和结状神经节的分布。结果显示：1、原位杂交;在三种感觉神经节中,95%左右的神经节细胞为P2X3mRNA阳性,中、小型神经节细胞的杂交信号一般要比大型的神经节细胞强一些,2、免疫组织化学;免疫组织化学结果与原位杂交结果基本一致。此外,在各神经节内,均显示出许多P2X3免疫阳性神经纤维,在足掌表皮也显示许多P2X3免疫反应阳性纤维,结果提示：P2X3不仅参与机体的痛觉的形成,还可能参与其它感觉,如本体感觉等的形成。     

人胎气管内胰岛淀粉样多肽免疫反应细胞的个体发生(英文)

为了进一步探讨胰岛淀粉样多肽（ＩＡＰＰ）的分布、定位以及它与其他生物活性物质的关系;用ＩＡＰＰ组织化学ＰＡＰ邻片双标法,观察了１８例１４～３８周人胎气管内ＩＡＰＰ免疫反应（ＩＲ）细胞的个体发生及与５羟色胺（５－ＨＴ）的关系。结果显示,胎１４周,气管粘膜表面的假复层柱状上皮中已有ＩＡＰＰ－ＩＲ细胞（Ｆｉｇ．１＆２）;１５周开始,粘膜固有层气管腺导管上皮中也出现分散的ＩＡＰＰ－ＩＲ细胞（Ｆｉｇ．３）;随胎龄增长,１７～２１周,气管上皮内ＩＡＰＰ－ＩＲ细胞逐渐增多;免疫染色加深（Ｆｉｇ．４＆５）,有些细胞发出细突直达腔面（Ｆｉｇ．６＆７）,粘膜下层的气管腺腺泡中也有ＩＡＰＰ－ＩＲ（Ｆｉｇ．８）; ２２～３８周,气管内 ＩＡＰＰ－ＩＲ 细胞又呈逐渐减少趋势,ＩＡＰＰ－ＩＲ仅出现在基底锥形细胞中（Ｆｉｇ．９＆１０）,且免疫染色较深。邻片未显５－ＨＴ－ＩＲ。本研究表明,人胎儿期气管上皮细胞内有ＩＡＰＰ的表达;且ＩＡＰＰ－ＩＲ细胞随胎期的发育而发生变化。     

Islet amyloid polypeptide (IAPP) in the gastrointestinal tract and pancreas of man and rat

Summary An immunohistochemical study for islet amyloid polypeptide (IAPP) was made on the gastrointestinal (GI) tract and pancreas of man and rat, using antisera raised against a synthetic peptide of C-terminal human IAPP (24–37) and a synthetic peptide of rat IAPP (18–37). A large number of IAPP-immunoreactive cells were found in the pyloric antrum, and a small number in the body of the stomach in both man and rat. Cytoplasmic processes extended out from the bipolar peripheral region of the immunoreactive cells, rather like neuronal processes, and some appeared to make contact with other immunoreactive cells. In addition, small numbers of immunoreactive cells were also seen in the duodenum and rectum, whereas they were absent from the jejunum, ileum and large intestine. An examination was made for evidence of colocalization of IAPP-immunoreactive material with material immunoreactive for gastrin, somatostatin, vasoactive intestinal polypeptide, pancreatic polypeptide, insulin, and glucagon, but none was found. IAPP-immunoreactive cells were also found in the pancreas of non-diabetic and non-insulin-dependent diabetic patients, but they were completely absent from a patient with insulin-dependent diabetes mellitus despite the presence of IAPP in the plasma. The results of these studies suggest that the peptide may have a biological role in situ in the GI tract and, in addition to the pancreas, may be a possible source of plasma IAPP.     

Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP

BACKGROUND: Several mouse strains expressing human islet amyloid polypeptide (IAPP) have been created to study development of islet amyloid and its impact on islet cell function. The tendency to form islet amyloid has varied strongly among these strains by factors that have not been elucidated. Because some beta cell granule components are known to inhibit IAPP fibril formation in vitro, we wanted to determine whether a mouse strain expressing human IAPP but lacking the nonamyloidogenic mouse IAPP is more prone to develop islet amyloidosis. MATERIALS AND METHODS: Such a strain was created by cross-breeding a transgenic mouse strain and an IAPP null mouse strain. RESULTS: When fed a fat-enriched diet, male mice expressing only human IAPP developed islet amyloid earlier and to a higher extent than did mice expressing both human and mouse IAPP. Supporting these results, we found that mouse IAPP dose-dependently inhibits formation of fibrils from human IAPP. CONCLUSIONS: Female mice did not develop amyloid deposits, although small extracellular amorphous IAPP deposits were found in some islets. When cultivated in vitro, amyloid deposits occurred within 10 days in islets from either male or female mice expressing only human IAPP. The study shows that formation of islet amyloid may be dependent on the environment, including the presence or absence of fibril inhibitors or promoters.     

Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus

We have cloned and sequenced a human islet amyloid polypeptide (IAPP) cDNA. A secretory 89 amino acid IAPP protein precursor is predicted from which the 37 amino acid IAPP molecule is formed by amino- and carboxyterminal proteolytic processing. The IAPP peptide is 43-46% identical in amino acid sequence to the two members of the calcitonin gene-related peptide (CGRP) family. Evolutionary conserved proteolytic processing sites indicate that similar proteases are involved in the maturation of IAPP and CGRP and that the IAPP amyloid polypeptide is identical to the normal proteolytic product of the IAPP precursor. A synthetic peptide corresponding to a carboxyteminal fragment of human IAPP is shown to spontaneously form amyloid-like fibrils in vitro. Antibodies against this peptide cross-react with IAPP from species that develop amyloid in pancreatic islets in conjunction with age-related diabetes mellitus (human, cat, racoon), but do not cross-react with IAPP from other tested species (mouse, rat, guinea pig, dog). Thus, a species-specific structural motif in the putative amyloidogenic region of IAPP is associated with both amyloid formation and the development of age-related diabetes mellitus. This provides a new molecular clue to the pathogenesis of this disease.     

Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption

Islet amyloid polypeptide (IAPP) is a 37-amino acid amyloid protein intimately associated with pancreatic islet β-cell dysfunction and death in type II diabetes. In this study, we combine spectroscopic methods and microscopy to investigate α-helical IAPP-membrane interactions. Using light scattering and fluorescence microscopy, we observe that larger vesicles become smaller upon treatment with human or rat IAPP. Electron microscopy shows the formation of various highly curved structures such as tubules or smaller vesicles in a membrane-remodeling process, and spectrofluorometric detection of vesicle leakage shows disruption of membrane integrity. This effect is stronger for human IAPP than for the less toxic rat IAPP. From CD spectra in the presence of different-sized vesicles, we also uncover the membrane curvature-sensing ability of IAPP and find that it transitions from inducing to sensing membrane curvature when lipid negative charge is decreased. Our in vivo EM images of immunogold-labeled rat IAPP and human IAPP show both forms to localize to mitochondrial cristae, which contain not only locally curved membranes but also phosphatidylethanolamine and cardiolipin, lipids with high spontaneous negative curvature. Disruption of membrane integrity by induction of membrane curvature could apply more broadly to other amyloid proteins and be responsible for membrane damage observed in other amyloid diseases as well.     

Amyloid in the pancreatic islets of the cougar (Felis concolor) is derived from islet amyloid polypeptide (IAPP)

1. Islet amyloid isolated from the pancreas of a 20-year-old cougar (Felis concolor) was dissolved and purified by gel permeation and reversed phase HPLC for amino acid sequence analysis. 2. N-Terminal amino acid sequence analysis of the purified protein revealed a primary structure (positions 1-28) identical to islet amyloid polypeptide (IAPP) from domesticated cats. 3. IAPP from the cougar, like IAPP from the human and domesticated cat, incorporates an inherently amyloidogenic AILS sequence at positions 25-28.     

Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis

We have examined a series of overlapping peptide fragments from the 8-20 region of human islet amyloid polypeptide (IAPP) with the objective of defining the smallest fibril-forming domain. Peptide fragments corresponding to LANFLV (residues 12-17) and FLVHSS (residues 15-20) were strong enhancers of beta-sheet transition and fibril formation. Negative stain electron microscopy illustrated the ability of these peptide fragments to form fibrils independently when incubated alone in solution. Circular dichroism analysis revealed that when full-length human IAPP was incubated in the presence of these two fragments, fibrillogenesis was accelerated. While the two fragments, LANFLV and FLVHSS, were able to enhance the recruitment of additional IAPP molecules during fibril formation, the "seeding" activity of these peptides had no effect on altering IAPP-induced cytotoxcity as determined by cell culture studies. Therefore, this study has identified two internal IAPP peptide fragments within the 8-20 domain that may have a role in enhancing the folding and aggregation of human IAPP. These fragments are the smallest sequences identified, within the 8-20 region of hIAPP, that can independently form fibrils, and that can interact with IAPP to assemble into fibrils with characteristics similar as those formed by human IAPP alone.     

Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas

Islet amyloid polypeptide (IAPP) is a recently discovered pancreatic islet hormone which is stored with insulin in the secretory vesicles of beta cells. Several lines of evidence suggested that IAPP might affect glucose-stimulated insulin secretion and, therefore, might play a role in the development of impaired insulin secretion which is typical of type 2 diabetes. In this study, the effects of human IAPP (amide) on glucose-stimulated insulin secretion was evaluated in the isolated perfused rat pancreas. IAPP in concentrations from 5 x 10(-12) to 10(-7) M had no significant effects on insulin secretion. IAPP, therefore, does not appear to be a significant modulator of glucose-stimulated insulin secretion at concentrations that are physiologically relevant.     

Spontaneous pancreatic islet amyloidosis in 40 baboons

Spontaneous amyloidosis occurs in many nonhuman primate species but remains difficult to diagnose and treat. Nonhuman primates continue to offer promise as animal models in which to study amyloidosis in humans. Amyloidosis was not diagnosed clinically but was found histologically in four male and 36 female baboons. The baboons averaged 18 years of age at death (range, 7-28 years). Clinical signs, if present, were hyperglycemia and cachexia. Blood glucose values were elevated in 12 of 30 baboons with available clinical pathology data. Four baboons had been clinically diagnosed as diabetic and three were treated with insulin. Amyloid was found in the islets of Langerhans of the pancreas in 40 baboons; 35 baboons had amyloid only in the islets of Langerhans. Amyloid was found in nonislet tissue of baboons as follows: five, nonislet pancreas; four, intestine and adrenal; three, kidney; two, prostate and spleen; and one each, lymph node, liver, gall bladder, stomach, tongue, urinary bladder, and salivary gland. Sections of paraffin-embedded tissues were evaluated for amyloid with hematoxylin and eosin (HE) and congo red (CR) staining, and using immunohistochemistry for human islet amyloid polypeptide (IAPP), calcitonin gene-related peptide (CGRP), glucagon, pancreatic polypeptide (PP), somatostatin (SS), and porcine insulin. Islet amyloid was positive with HE in 40 baboons, with CR in 39 baboons, and with IAPP and CGRP in 35 baboons. IAPP and CGRP only stained islet amyloid. PP, SS, glucagon, and porcine insulin did not stain amyloid. Islet amyloidosis in the baboon appears to be difficult to diagnose clinically, age-related, and similar to islet amyloidosis in other species. The baboon may be a good model for the study of islet amyloidosis in humans.     

Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species

Amyloid deposits in the islets of Langerhans occur in association with type 2 diabetes mellitus (DM) in humans and cats and consist of a 37-amino-acid polypeptide known as islet amyloid polypeptide (IAPP). In order to find an explanation for the situation that islet amyloid (IA) does not develop in common rodent species, we have deduced the amino acid sequence of the IAPP molecule in mouse, rat and hamster. We find that a specific region of the molecule diverges to a high degree. Synthetic peptides corresponding to this region of human and hamster IAPP were compared for their ability to form amyloid fibrils in vitro. Whereas the human peptide readily formed fibrils with amyloid character, the hamster peptide completely lacked this property. We suggest this to be a likely explanation for the differences in IA formation between humans and rodents and discuss our findings in relation to the type 2 DM syndrome.